T. Rowe Price Investment Management »

Neumora Therapeutics shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $69M 5.2M 13.21
2024-06-30 $50M 5.1M 9.83
2024-03-31 $49M 3.6M 13.75

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Fortive Corp Comm Stk (FTV)
Amazon Comm Stk (AMZN)
PTC Comm Stk (PTC)
Unitedhealth Group Comm Stk (UNH)
Revvity Comm Stk (RVTY)
Danaher Corporation Comm Stk (DHR)
Becton Dickinson & Co Comm Stk (BDX)
Roper Technologies Comm Stk (ROP)
Marvell Technology Comm Stk (MRVL)
Martin Marietta Matls Comm Stk (MLM)
Alphabet Comm Stk (GOOGL)
Apple Comm Stk (AAPL)
Hologic Comm Stk (HOLX)

View all positions for T. Rowe Price Investment Management

Top funds holding Neumora Therapeutics

Softbank Group Corp
BlackRock
T. Rowe Price Investment Management
BlackRock
MIC Capital Management UK
ICONIQ Capital
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Vanguard Group
Siren
EcoR1 Capital
Geode Capital Management
Johnson & Johnson
Avidity Partners Management
OrbiMed Advisors
State Street Corporation

View all funds holding Neumora Therapeutics